Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials

Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials

Abstract Background Neoadjuvant chemotherapy (NC) is a cornerstone in the management of resectable esophageal squamous cell carcinoma (ESCC). The integration of PD-1/PD-L1 inhibitors into NC (NIC) regimens has shown promise; however, its efficacy and safety remain uncertain. This meta-analysis aims...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye Zhang, Jie Chen, Fenglian Yu, Wenxiong Zhang, Yingmei Zhong
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Gastroenterology
Subjects:
Neoadjuvant
PD-1/PD-L1 inhibitors
Chemotherapy
Esophageal squamous cell carcinoma
Meta-analysis
Randomized controlled trials
Online Access:https://doi.org/10.1186/s12876-025-04030-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-04030-7

Similar Items